News Releases

Select year
Categories

Myriad Genetics Hires Five Senior Leaders to Advance Commercial Growth Plans

Dec 19, 2022 | Corporate

Read more

Myriad Genetics to Present New Data at San Antonio Breast Cancer Symposium Showcasing Advancements in Breast Cancer Risk Assessment and Treatment

Nov 29, 2022 | Products | Corporate

Read more

Myriad Genetics Expands Board of Directors with Election of Paul M. Bisaro as New Board Member

Oct 31, 2022 | Corporate

Read more

Family Cancer History Still a Mystery to Many Women, Myriad Genetics Survey Finds

Sep 28, 2022 | Corporate

Read more

Myriad Genetics Issues Inaugural Environmental, Social and Governance Report

Jun 28, 2022 | Corporate

Read more

Myriad Genetics CEO Paul Diaz to Speak at Goldman Sachs 43rd Annual Global Healthcare Conference

Jun 09, 2022 | Corporate

Read more

Myriad Genetics Showcases Advancements in Precision Medicine with Recent Oncology Portfolio Expansion and New Data Presentations at ASCO 2022

May 26, 2022 | Corporate

Read more

Myriad Genetics CEO Paul Diaz to Speak at Bank of America Securities 2022 Healthcare Conference

May 04, 2022 | Corporate

Read more

Myriad Genetics Expands Partnership with Intermountain Precision Genomics to Add Liquid Biopsy Therapy Selection Offering to Portfolio of Precise™ Oncology Solutions

May 03, 2022 | Pipeline | Corporate

Read more

Myriad Genetics to Release First-Quarter 2022 Financial Results on May 5, 2022

Apr 28, 2022 | Financial | Corporate

Read more

Myriad Genetics Advances Precision Oncology with New Precise™ Solutions, Combines Genetic Insights from Multiple Tests to Guide Treatment Decisions and Improve Patient Care

Mar 14, 2022 | Corporate | Products

Read more

Myriad Genetics Named to Fast Company’s Annual List of World’s Most Innovative Companies

Mar 08, 2022 | Corporate

Read more

Myriad Genetics CEO Paul Diaz to Speak at 42nd Annual Cowen Health Care Conference

Mar 02, 2022 | Corporate

Read more

Myriad Genetics to Release Fourth-Quarter 2021 Financial Results on February 24, 2022

Feb 16, 2022 | Corporate | Financial

Read more

Myriad Genetics to Present at Two Upcoming Healthcare Conferences

Feb 14, 2022 | Corporate

Read more

Myriad Genetics CEO Paul Diaz to Speak at 40th Annual J.P. Morgan Health Care Conference

Jan 05, 2022 | Corporate | Financial

Read more

Myriad Genetics Chief Scientific Officer Jerry Lanchbury Retires after 19 Years of Service

Jan 04, 2022 | Corporate

Read more